Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
11.52 USD | -7.17% | +3.47% | +121.29% |
04:22pm | Stoke Therapeutics Appoints Thomas Leggett CFO | MT |
02:00pm | Stoke Therapeutics, Inc. Announces Executive Changes, Effective May 7, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+121.29% | 647M | |
+2.34% | 42.75B | |
+47.70% | 41.61B | |
+11.96% | 41.34B | |
-12.36% | 26.59B | |
+8.73% | 25.49B | |
-22.82% | 18.12B | |
+30.86% | 12.24B | |
-1.47% | 11.76B | |
+8.48% | 11B |
- Stock Market
- Equities
- STOK Stock
- News Stoke Therapeutics, Inc.
- Canaccord Genuity Adjusts Stoke Therapeutics Price Target to $21 From $18, Maintains Buy Rating